6-Bromo-1-methylbenzimidazole - CAS 53484-16-5
Catalog: |
BB028244 |
Product Name: |
6-Bromo-1-methylbenzimidazole |
CAS: |
53484-16-5 |
Synonyms: |
6-bromo-1-methylbenzimidazole; 6-bromo-1-methylbenzimidazole |
IUPAC Name: | 6-bromo-1-methylbenzimidazole |
Description: | 6-Bromo-1-methylbenzimidazole (CAS# 53484-16-5) is a useful research chemical. |
Molecular Weight: | 211.06 |
Molecular Formula: | C8H7BrN2 |
Canonical SMILES: | CN1C=NC2=C1C=C(C=C2)Br |
InChI: | InChI=1S/C8H7BrN2/c1-11-5-10-7-3-2-6(9)4-8(7)11/h2-5H,1H3 |
InChI Key: | QDXJAGXUNYFXRG-UHFFFAOYSA-N |
Boiling Point: | 317.2 °C at 760 mmHg |
Density: | 1.6 g/cm3 |
Appearance: | Solid |
LogP: | 2.33580 |
GHS Hazard Statement: | H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021114314-A1 | Novel heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases | 20191214 |
WO-2021115489-A1 | Novel heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases | 20191214 |
WO-2021041237-A1 | Thyroid hormone receptor beta agonist compounds | 20190823 |
BR-112020020104-A2 | heterobyclic inhibitors of mat2a and methods of use for the treatment of cancer | 20180330 |
US-2021115045-A1 | Heterobicyclic inhibitors of mat2a and methods of use for treating cancer | 20180330 |
Complexity: | 151 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 209.97926 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 209.97926 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 17.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Benzimidazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS